Brexit and the pharmaceutical industry webinar

Please join our Hogan Lovells Life Sciences and Health Care team for a complementary webinar on Tuesday, 2 February, to examine the impact of Brexit and the EU-UK Trade and Cooperation...

Virtual health: What's on the horizon for telehealth and remote monitoring?

As the world responds to the COVID-19 pandemic, physicians and patients are increasingly turning to virtual health solutions, including telehealth and remote monitoring, as a central facet...

How COVID-19 is changing the clinical trials landscape

Among the numerous repercussions of the COVID-19 pandemic, life sciences companies and academic medical centers are now faced with significant disruptions and threats to their clinical...

Boston: Life Sciences and Health Care Horizons 2019

The fast pace of innovation in the life sciences and health care industry is quickly transforming the health and vitality of the world we live in. It can be a challenge to keep up, let...

The impact of Brexit on the pharmaceutical and medical device industries

Our European Life Sciences Regulatory team has been examining the potential consequences of Brexit for the pharmaceutical and medical device industries since before the results of the...

What's Brexit got to do with EU?

The next few days may or may not be a turning point for Brexit negotiations. But whilst a “no deal” scenario is still on the cards, it is more critical than ever for...

The European regulatory framework and recent developments in telehealth

On 18 October 2018 we hosted a complimentary webinar discussing the recent regulatory changes of telehealth services, potential future developments, and some of the key legal issues to...

Patient support programs: Understanding legal risks

Patient support programs – from nursing and reimbursement support services to copay support mechanisms – are industry-wide and increasingly important to patients facing an...

Loading data